Measles Vaccination Efficacy: Comparing Disease Severity and Complications in Kyrgyz Pediatric Patients

  • Elena Khalupko Department of Children’s Infectious Diseases, IK Akhunbaev Kyrgyz State Medical Academy, Bishkek, Kyrgyzstan
  • Svetlana Chechetova Department of Children’s Infectious Diseases, IK Akhunbaev Kyrgyz State Medical Academy, Bishkek, Kyrgyzstan
  • Zuura Dzholbunova Department of Children’s Infectious Diseases, IK Akhunbaev Kyrgyz State Medical Academy, Bishkek, Kyrgyzstan
  • Meerim Baialieva Department of Children’s Infectious Diseases, IK Akhunbaev Kyrgyz State Medical Academy, Bishkek, Kyrgyzstan
  • Elena Radchenko Department of Children’s Infectious Diseases, IK Akhunbaev Kyrgyz State Medical Academy, Bishkek, Kyrgyzstan
  • Damirakhan Chynyeva Department of Children’s Infectious Diseases, IK Akhunbaev Kyrgyz State Medical Academy, Bishkek, Kyrgyzstan
  • Madina Mambetova Department of Children’s Infectious Diseases, IK Akhunbaev Kyrgyz State Medical Academy, Bishkek, Kyrgyzstan
  • Gulzhan Omurkulova Department of Obstetrics and Gynecology named after MS Musuraliev, IK Akhunbaev Kyrgyz State Medical Academy, Bishkek, Kyrgyzstan
  • Cholpon Imankulova Department of Obstetrics and Gynecology named after MS Musuraliev, IK Akhunbaev Kyrgyz State Medical Academy, Bishkek, Kyrgyzstan
Keywords: Measles, vaccination, eradication, outbreak, Kyrgyzstan.

Abstract

Introduction: Measles remains a global health challenge, particularly in regions with low vaccination rates.

Aim: This retrospective study examined measles progression in vaccinated and unvaccinated children in Kyrgyzstan during a resurgence between 2024 and 2025.

Methods: The study included 105 pediatric patients (aged 1-6 years) admitted to the Republican Clinical Infectious Diseases Hospital in Bishkek, categorized by vaccination status: Group I (unvaccinated, n=55) and Group II (vaccinated with at least one dose of measles-containing vaccine, n=50).

Results: Clinical presentation, complications, and treatment data were collected from the medical records. Results showed that unvaccinated children experienced more severe measles (67.3% vs. 38.0%, p<0.01) and had more complications (67.3% vs. 48.0%, p<0.05) than vaccinated children. Fever duration, hospital stay, and antibiotic treatment were longer in the unvaccinated children (p<0.001). Vaccination was associated with a 59% reduction in severe disease (RR=0.409) and complications (RR=0.403). The most common complication was pneumonia, affecting 87.3% of unvaccinated and 86.0% of vaccinated children.

Conclusion: The findings highlight the protective benefits of vaccination in reducing disease severity and complications, emphasizing the importance of high vaccination coverage to prevent outbreaks.

References

1. Minta AA, Ferrari M, Antoni S, Portnoy A, Sbarra A, Lambert B, et al. Progress Toward Measles Elimination - Worldwide, 2000-2022. MMWR Morb Mortal Wkly Rep. 2023;72(46):1262-1268.
2. Minta AA, Ferrari M, Antoni S, Lambert B, Sayi TS, Hsu CH, et al. Progress Toward Measles Elimination - Worldwide, 2000-2023. MMWR Morb Mortal Wkly Rep. 2024;73(45):1036-1042
Published
2025-12-31